Role of sarcolemmal KATP channels in cardioprotection against ischemia/reperfusion injury in mice
J. Clin. Invest. Masashi Suzuki, et al. 109:509
doi:10.1172/JCI14270 [Go to this article.]

Figure 3
Effects of metabolic inhibition with a glucose-free, DNP-containing (50 μM) solution and coapplication of glibenclamide (GLB; 10 μM) on the action potentials recorded from ventricular cells of WT (a) and KO mice (b). (c) Summarized changes of APD90 in WT (n = 8) and KO cells (n = 8). Values are expressed as mean ± SE. *P < 0.01 versus control (CON); #P < 0.01 versus DNP, no glucose.